STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Tilgjengelig fra:

Sanofi-Aventis Australia Pty Ltd

INN (International Name):

prochlorperazine mesilate

Legemiddelform:

Injection

Sammensetning:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Administreringsrute:

Intramuscular

Enheter i pakken:

10 x 1 mL

Resept typen:

(S1) This Schedule is intentionally blank

Indikasjoner:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Produkt oppsummering:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Autorisasjon status:

Licence status A

Autorisasjon dato:

2007-07-16